318 results on '"Lee, Dong-In"'
Search Results
2. Simple Sugar and Sugar-Sweetened Beverage Intake During Adolescence and Risk of Colorectal Cancer Precursors
3. Tumor Necrosis Factor-producing T-regulatory Cells Are Associated With Severe Liver Injury in Patients With Acute Hepatitis A
4. The Prevalence of Celiac Disease Among Patients With Nonconstipated Irritable Bowel Syndrome Is Similar to Controls
5. 328: REAL-WORLD TREATMENT OUTCOME WITH PROTEASE INHIBITOR (PI) VS NON-PI DIRECT ACTING ANTIVIRALS (DAAS) IN DECOMPENSATED HCV CIRRHOSIS: A REAL-C STUDY
6. EP1326: ANTI-INFLAMMATORY EFFECT OF EXTRACELLULAR VESICLES ISOLATED FROM ROSEBURIA INTESTINALIS IN RAW264.7 CELL LINE
7. EP1184: THE PREDICTOR OF MALIGNANT IN INTRADUCTAL PAPILLARY NEOPLASM OF THE BILE DUCT
8. EP1334: EFFECTS OF THE EXTRACELLULAR VESICLES DERIVED FROM BLAUTIA OBEUM ON PARKINSON'S DISEASE
9. Sa1559: RISK FACTORS AND PROGNOSIS OF PNEUMOCYSTIS JIROVECI PNEUMONIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A NATIONWIDE POPULATION-BASED STUDY IN SOUTH KOREA
10. Tu1093: ASSOCIATION BETWEEN METABOLIC SYNDROME AND THE RISK OF EARLY-ONSET COLORECTAL CANCER DEPENDING ON TUMOR LOCATION
11. Sa1131: ASSOCIATION OF SMOKING AND ALCOHOL CONSUMPTION WITH YOUNG-ONSET GASTRIC CANCER: A NATIONWIDE POPULATION-BASED COHORT STUDY
12. Sa1616 MORTALITY RATES AMONG PATIENTS SUCCESSFULLY TREATED FOR HEPATITIS C: A REAL WORLD MULTINATIONAL COHORT STUDY
13. Mo1467 REAL WORLD COMPARISON BETWEEN CAPECITABINE AND 5-FLUOROURACIL AS ADJUVANT THERAPY IN BILIARY TRACT CANCER
14. Sa1780 THE POTENTIAL OF MOLECULAR REMISSION: TISSUE NEUTROPHIL ELASTASE IS BETTER THAN HISTOLOGICAL ACTIVITY FOR PREDICTING LONG-TERM RELAPSE IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION
15. 1245 RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZASTAPRAZAN COMPARED WITH ESOMEPRAZOLE IN EROSIVE ESOPHAGITIS [ZASTAPRAN EROSIVE REFLUX OESOPHAGITIS-1 STUDY (ZERO-1)]
16. Functional Switching of TGF-β1 Signaling in Liver Cancer via Epigenetic Modulation of a Single CpG Site in TTP Promoter
17. NIPEP-IBD; A SYNTHETIC PEPTIDE TARGETING NOVEL MOLECULE, INTEGRIN BETA 1, TO RESTITUTE INTESTINAL EPITHELIAL CELLS FOR INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT
18. Huge Periampullary Mass: Where Is the Origin?
19. Su490 EFFECTIVE GROWTH INHIBITION OF CLOSTRIDIOIDES DIFFICILE BY INTESTINAL ISOLATES(LIVE FORM BACTERIA AND CELL-FREE SUPERNATANT)FROM HUMAN FECES
20. Sa613 ANTI-INFLAMMATORY EFFECT OF EV (EXTRACELLULAR VESICLES) ISOLATED FROM BIFIDOBACTERIUM BREVE IN RAW264.7 MACROPHAGE
21. Su534 ANTI-INFLAMMATORY EFFECT OF EV (EXTRACELLULAR VESICLES) ISOLATED FROM LACTOBACILLUS JOHNSONII IN COLON CELL
22. 658 LIVER COMPLICATIONS IN UNTREATED TREATMENT-INELIGIBLE VERSUS TREATED TREATENT-ELIGIBLE PATIENTS WITH HEPATITIS B
23. 510 PROGRESSION OF CHRONIC HEPATITIS B TO CIRRHOSIS AND HEPATOCELLULAR CARCINOMA BY AGE, SEX, DISEASE ACTIVITY, AND TREATMENT STATUS USING AASLD CRITERIA
24. EP81 COMPARISON OF EFFICACY AND SAFETY BETWEEN REDUCED-DOSE AND MODIFIED-DOSE FOLFIRINOX IN PATIENTS WITH PANCREATIC CANCER
25. EP82 CLINICAL BENEFIT OF GEMCITABINE-BASED CHEMOTHERAPY FOR EXTREME ELDERLY PATIENTS WITH PANCREATIC CANCER: A NATIONWIDE POPULATION-BASED STUDY
26. Tu1404 A PRELIMINARY RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL ON THE SAFETY AND EFFICACY OF HUMAN BONE-MARROW DERIVED CLONAL MESENCHYMAL STEM CELLS FOR MODERATELY SEVERE TO SEVERE ACUTE PANCREATITIS
27. Tu1108 THE PERSISTENCE OF HYPERTRIGLYCERIDEMIA AND THE RISK OF EARLY ONSET COLORECTAL CANCER ACCORDING TO TUMOR SUBSITES: A NATIONWIDE POPULATION-BASED STUDY
28. Mo1908 GUT MICROBIOME SIGNATURE OF METABOLICALLY HEALTHY OBESE INDIVIDUALS ACCORDING TO ANTHROPOMETRIC, METABOLIC AND INFLAMMATORY PARAEMTERS
29. Su1404 CLINICAL IMPLICATION OF KRAS MUTATION OF PLASMA CELL-FREE DNA IN PANCREATIC ADENOCARCINOMA: A PROSPECTIVE MULTICENTER COHORT STUDY
30. Sa1875 GASTRIC MICROBIOME SIGNATURE FOR PREDICTING METACHRONOUS RECURRENCE AFTER ENDOSCOPIC RESECTION OF GASTRIC NEOPLASMS: A PILOT STUDY
31. Mo1540 THE EFFICACY AND SAFETY OF GCWB104 (FLOS LONICERA EXTRACT) IN FUNCTIONAL DYSPEPSIA: A SINGLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
32. Su1379 ANNUAL ERADICATION RATE OF BISMUTH-CONTAINING QUADRUPLE THERAPY AS SECOND-LINE TREATMENT FOR HELICOBACTER PYLORI INFECTION: A 15-YEAR PROSPECTIVE STUDY AT A TERTIARY HOSPITAL IN KOREA
33. Mo1492 PREVALENCE OF NON-LIVER COMORBIDITIES, MODETATE/SEVERE STEATOSIS, NASH AND LIVER FIBROSIS IN ASIAN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): A SYSTEMIC REVIEW AND META-ANALYSIS OF 128 STUDIES
34. Sa1924 COMPOSITIONAL AND FUNCTIONAL CHANGES OF GUT MICROBIOTA IN IRRITABLE BOWEL SYNDROME
35. Tu1912 NUTRIENT-DEPENDENT PHYSIOLOGICAL AND PROTEOMIC ANALYSIS OF MUCIN DEGRADING BACTERIA REVEALS METABOLIC INSIGHT INTO MUCOSA-ASSOCIATED MICROBIOTA IN THE HUMAN GUT
36. Tu1332 EFFICACY OF A HIGH-DOSE PROTON PUMP INHIBITOR IN PATIENTS WITH EXTRAESOPHAGEAL SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE: A SINGLE CENTER, RANDOMIZED, OPEN-LABEL TRIAL
37. Tu1925 SEX- AND COLORECTAL CANCER-ASSOCIATED CHANGES IN THE GUT MICROBIOTA FOLLOWING 17β-ESTRADIOL SUPPLEMENTATION IN ICR MOUSE STRAIN
38. Tu1370 EFFICACY OF DA-5204 FOR GASTROESOPAGEAL REFLUX DISEASE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY
39. Mo1515 DEVELOPMENT AND REGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) OVERALL AND IN SELECTED PATIENT COHORTS: A META-ANALYSIS OF 32 LONGITUDINAL STUDIES AND 179,398 ASIAN PATIENTS
40. Mo1045 EFFECTS OF 17β-ESTRADIOL ON COLORECTAL CANCER DEVELOPMENT BY AN AZOXYMETHANE/DEXTRAN SULFATE SODIUM TREATMENT IN NRF2 KNOCKOUT MICE
41. Tu1015 GASTRIC ADENOMA INCREASES THE RISK FOR NOT ONLY METACHRONOUS GASTRIC CANCER BUT ALSO COLORECTAL AND PANCREATIC CANCERS: A NATIONWIDE POPULATION-BASED COHORT STUDY
42. Sa1673 RESTING HEART RATE IS AN INDEPENDENT PREDICTOR OF ADVANCED COLORECTAL ADENOMA DEVELOPMENT
43. Mo1091 LOW GRADE GASTRIC MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA : CLINICOPATHOLOGIC FACTORS ASSOCIATED WITH HELICOBACTER PYLORI ERADICATION AND TUMOR REGRESSION
44. Su1983 HIGHER LEVELS OF FECAL CALPROTECTIN PREDICT THE FLARE-UP OF DISEASE DURING INTERNATIONAL AIR TRAVEL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
45. Su1215 GROWTH INHIBITION OF CLOSTRIDIUM DIFFICILE BY THE INTESTINAL ISOLATES FROM HUMAN FECES: INVESTIGATION OF KEY MICROBIOTA IN FMT (FECAL MICROBIOTA TRANSPLANTATION)
46. Mo1485 A META-ANALYSIS OF MORTALITY AND NON-LIVER COMORBIDITY OUTCOMES IN ASIAN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) - POOL ESTIMATES FROM 29 STUDIES AND 725,573 PATIENTS
47. Su1709 ESCHERICHIA COLI AS A MODEL SYSTEM TO STUDY THE MITOCHONDRIAL MUTATIONS IN BILIARY ATRESIA
48. P142 TARGETED COLON DELIVERY OF NIPEP-IM-0127 PEPTIDE FOR INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT
49. Mo1271 – The Influence of H. Pylori Infection on the Expression of H+,K+-Atpase and Interleukin-1ß According to Intestinal Metaplasia
50. Su1283 – Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy in First-Line Treatment of Helicobacter Pylori Infection: A Nationwide Randomized Trial in Korea
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.